Article
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.
AIDS (London, England) - 30 Jan 2008
Bannister Wendy P, Ruiz Lidia, Cozzi-Lepri Alessandro, Mocroft Amanda, Kirk Ole, Staszewski Schlomo, Loveday Clive, Karlsson Anders, Monforte Antonella d'Arminio, Clotet Bonaventura, Lundgren Jens D
Abstract excerpt
OBJECTIVE: To compare virological outcome and genotypic resistance profiles in HIV-1-infected patients starting non-nucleoside reverse transcriptase inhibitor (NNRTI)-containing regimens. METHODS: NNRTI-naive patients were included who started treatment with nevirapine (NVP) or efavirenz (EFV) with genotypic resistance test results available at time of initiation (baseline). Virological failure was defined as two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.